SANTA CLARA, Calif. — Affymetrix, Inc. (NASDAQ:AFFX) is introducing several new agrigenomic genotyping solutions this week at the annual Plant and Animal Genome Conference (PAG XXIV). Following the company’s acquisition of Eureka Genomics in mid-2015, Affymetrix is introducing Eureka™ Genotyping Solution for low-cost, low-plex genotyping by sequencing (GBS). The company is also introducing two new […]
Rockville, MD — OriGene Technologies, Inc. (OriGene), a leading manufacturer of high quality antibodies and gene-centric tools, announced today that they have been awarded a Phase II SBIR contract from the National Cancer Institute (NCI) to develop high-affinity, anti-peptide antibodies for mass-spectrometry-based serum biomarker detection/ quantification assays. OriGene’s winning of this grant is rooted in […]
NEW YORK, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced that it has reached and finalized a settlement with Agilent Technologies, Inc. (NYSE: A) involving payment of $9 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197. Today’s settlement resolving the disputes between Enzo and Agilent impacts only one […]
BOTHELL, WA – BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers (“BioLife” or the “Company”), today announced that privately held, Vancouver, BC-based STEMCELL Technologies will test […]
NEW YORK, NY – Enzo Biochem Inc. (NYSE:ENZ) announced the results of its Annual Shareholders Meeting today and updated shareholders on its businesses. Shareholders voted overwhelmingly to re-elect the Company’s nominees, Gregory M. Bortz and Dov Perlysky, as Class I directors to hold office for a term of three years. Shareholders also ratified the selection […]
Fremont, CA –– DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announces the expansion of its PathHunter® cell-based assays portfolio with the release of PathHunter Interleukin cell-based assays. Interleukins are a group of immune-modulatory cytokines that play a prominent role in immune system disorder-related diseases, making them […]
NEW YORK — Harris & Harris Group, Inc. (NASDAQ:TINY), an investor in transformative companies enabled by disruptive science, is pleased to note that its portfolio company, TARA Biosystems, Inc., raised $2.25 million in a seed financing to build commercial operations in New York City. Harris & Harris Group led the financing with participation from the […]
BANGALORE – Pandorum Technologies Pvt. Ltd., the Bangalore-based biotechnology startup working on tissue engineering, announced that it has developed artificial tissue that performs the functions of the human liver. These 3D printed living tissues enable affordable medical research with reduced animal and human trials, and will eventually lead to full scale transplantable organs. “This is […]
Leiden, The Netherlands — Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals. A panel of experts from BASF, Sanofi, GlaxoSmithKline, Abbvie, NC3Rs and renowned academic institutions has selected […]
CAMBRIDGE, Mass. — Emulate Inc. today announced an expanded research collaboration with Merck, known as MSD outside the United States and Canada, to deploy Emulate’s Organ-Chips across certain Merck discovery programs to improve models of human inflammatory diseases and better predict the potential human response of therapeutic candidates. The research will focus on using Emulate’s […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
